期刊
NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 29, 期 2, 页码 263-273出版社
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gft443
关键词
anemia; chronic kidney disease; hepcidin; iron; review
资金
- NIH [RO1-DK087727]
- Massachusetts General Hospital
Iron is essential for most living organisms but iron excess can be toxic. Cellular and systemic iron balance is therefore tightly controlled. Iron homeostasis is dysregulated in chronic kidney disease (CKD) and contributes to the anemia that is prevalent in this patient population. Iron supplementation is one cornerstone of anemia management in CKD patients, but has not been rigorously studied in large prospective randomized controlled trials. This review highlights important advances from genetic studies and animal models that have provided key insights into the molecular mechanisms governing iron homeostasis and its disturbance in CKD, and summarizes how these findings may yield advances in the care of this patient population.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据